These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 23909256

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH, Kang J, Jung YJ, Yoo B, Lee CK, Kim YG, Hong S, Shim TS, Jo KW.
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [Abstract] [Full Text] [Related]

  • 24. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D, Popović Grle S, Morović Vergles J, Čuković Čavka S, Jakopović M, Redžepi G, Boras Z, Baričević M, Samaržija M.
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [Abstract] [Full Text] [Related]

  • 25. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
    Hatzara C, Hadziyannis E, Kandili A, Koutsianas C, Makris A, Georgiopoulos G, Vassilopoulos D.
    Ann Rheum Dis; 2015 Oct; 74(10):1848-53. PubMed ID: 24854354
    [Abstract] [Full Text] [Related]

  • 26. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI, Sowah SA, Yeboah NY, Addo KK, Jackson-Sillah D.
    Int J Mycobacteriol; 2017 Oct; 6(1):27-33. PubMed ID: 28317801
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH, Won S, Choi CB, Sung YK, Song GG, Bae SC.
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting.
    Saidenberg-Kermanac'h N, Semerano L, Naccache JM, Brauner M, Falgarone G, Dumont-Fischer D, Guillot X, Valeyre D, Boissier MC.
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1307-14. PubMed ID: 22863801
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.
    Wu CY, Chiu HY, Tsai TF.
    PLoS One; 2019 Oct; 14(12):e0225112. PubMed ID: 31881026
    [Abstract] [Full Text] [Related]

  • 33. Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents.
    Scrivo R, Sauzullo I, Mengoni F, Iaiani G, Vestri AR, Priori R, Di Filippo E, Di Franco M, Spinelli FR, Vullo V, Mastroianni CM, Valesini G.
    Clin Rheumatol; 2012 Nov; 31(11):1567-75. PubMed ID: 22864811
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Influence of previous tuberculin skin test on serial IFN-γ release assays.
    Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, Ajassa C, Vullo V, Mastroianni CM.
    Tuberculosis (Edinb); 2011 Jul; 91(4):322-6. PubMed ID: 21664872
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Detecting latent tuberculosis infection during anti-tumor necrosis factor therapy.
    Ringrose JS, Sanche SE, Taylor-Gjevre RM.
    Clin Exp Rheumatol; 2011 Jul; 29(5):790-4. PubMed ID: 21961892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.